Bandar M. Alenezi

Dr. Bandar M. Alenezi

Optometry, Qassim University, Buraidah, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Experimental Eye Research
Verified
Journal Article
Closed access
Bandar M. AleneziBandar M. Alenezi
Bandar M. Alenezi
Ahmed KazailiAhmed Kazaili
Ahmed Kazaili
Riaz AkhtarRiaz Akhtar
Riaz Akhtar
HRHema Radhakrishnan
Hema Radhakrishnan

16 February 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
SASulaiman Aldakhil
Sulaiman Aldakhil
SASaif Hassan Alrasheed
Saif Hassan Alrasheed
RMRaghda Faisal Mutwaly
Raghda Faisal Mutwaly
Bandar M. AleneziBandar M. Alenezi
Bandar M. Alenezi
SASaad Alrabiah
Saad Alrabiah
BABashair Alnasser
Bashair Alnasser
Background: Visual impairment can significantly impact an individual’s performance, productivity, and overall quality of life. Objectives: The objective of this paper is to report the prevalence, causes, and risk factors associated with visual impairment in Qbah, a rural community in the Qassim Province of Saudi Arabia. Methods: A descriptive cross-sectional study was conducted in Qbah, a rural community, with 587 subjects aged 6 to 80 years. Data were collected as part of a major campaign by Qassim University, and each participant underwent a comprehensive eye examination. Finally, the visual impairment was classified based on the International Classification of Diseases 11th revision, 2018 (ICD-11). Results: The overall prevalence of presenting visual impairment was 159 (27.1%). This included mild visual impairment 84 (14.37%), moderate visual impairment 65 (11.7%), severe visual impairment, and blindness 5 (0.90%). The main causes of visual impairment were uncorrected refractive errors (UREs), at 132 (83.0%), followed by amblyopia, at 14 (8.8%), and cataract, at 9 (5.7%). The prevalence of hyperopia, myopia, and astigmatism was 134 (22.8%), 174 (29.6%), and 13 (2.2%), respectively. Regression analysis revealed that the odds for visual impairment were 2.71 times higher in the elderly compared to the young participants. Women have 2.234 times higher odds of visual impairment compared to men, while the odds of visual impairment were 14.83 times higher in the participants with the URE compared to the emmetropic participants. Almost two-thirds of participants (65.8%) reported never having had an eye examination before. Conclusions: Visual impairment was common in the community, especially among older people and females, and URE was the main cause of visual impairment, followed by amblyopia and cataract. Considerable subjects reported never having had an eye examination before; this highlights the challenges in accessing healthcare in rural areas. These findings emphasize the importance of improving healthcare accessibility in rural regions.

17 October 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SASaif Hassan Alrasheed
Saif Hassan Alrasheed
MAMuhammed S. Alluwimi
Muhammed S. Alluwimi
SASaleh Alshammeri
Saleh Alshammeri
SASulaiman Aldakhil
Sulaiman Aldakhil
MMMajid A. Moafa
Majid A. Moafa
Bandar M. AleneziBandar M. Alenezi
Bandar M. Alenezi
To assess the prevalence of childhood visual impairment and refractive errors, as well as the causes and risk factors associated with visual impairment among children in the Qassim region of Saudi Arabia. This cross-sectional study included 850 children (aged 6–17 years) from six randomly selected primary schools in the Qassim region, conducted from March to May 2024. The study used the modified Refractive Error Study in Children (RESC) protocol. Refractive error was objectively assessed using a non-cycloplegic autorefractometer. Anterior eye examinations were performed using slit lamp biomicroscopy, while posterior segment examinations were conducted using a direct ophthalmoscope and 90 D fundus biomicroscopy. Visual impairment was classified according to the International Classification of Diseases, 11th revision (ICD-11), 2018. The prevalence of presenting childhood visual impairment was 25.5%, reduced to 7.1% with best correction. Presenting visual impairment included mild impairment in 15.5% of participants, moderate in 6.4%, severe in 2.1%, and 1.5% were classified as blind. The leading cause of childhood visual impairment was uncorrected refractive error (67.3%), followed by amblyopia (23.0%); cataract (5.5%); and congenital disorders (5.1%). The prevalence of hyperopia, myopia, and astigmatism were 30.5%, 19.3%, and 11.3%, respectively. The regression analysis showed that males had lower odds of visual impairment compared to females (OR: 0.57; P = 0.001). Children who never had their eyes checked had lower odds of visual impairment compared to those who had regular eye examinations (OR: 0.32; P < 0.001). Additionally, emmetropic children had lower odds of visual impairment compared to those with uncorrected refractive errors (OR: 0.22; P < 0.001). This study found a high prevalence of childhood visual impairment and refractive errors, with uncorrected refractive errors being the leading cause. Regular eye examinations and corrective measures are essential. Males had lower odds of visual impairment compared to females. These findings highlight the need for targeted interventions to enhance eye care services and reduce visual impairment in children.

17 January 2021 in Acta Ophthalmologica
Verified
Journal Article
Open access
PDF file
Bandar M. AleneziBandar M. Alenezi
Bandar M. Alenezi
FKFadil Khoyratty
Fadil Khoyratty
SBSusmito Biswas
Susmito Biswas
HRHema Radhakrishnan
Hema Radhakrishnan
Purpose: The study aims to investigate the effectiveness of corneal cross‐linking (CXL) treatment in keratoconus patients.Methods: A total of 167 eyes of 159 progressive keratoconic patients (109 males and 58 females) aged 19 to 52 years old were included in the study. Epithelium debridement was performed for all patients, followed by riboflavin and UV‐A accelerated CXL (9.86 mW/cm2 for 9 min). To explore the effect of keratoconus severity on CXL outcomes, patients were divided into two groups based on the preoperative measurements of maximum keratometry (Kmax): Group A (Kmax < 62D) and Group B (Kmax ≥ 62 D). Corrected distance visual acuity (CDVA), corneal curvature and thickness were measured pre‐CXL and at 1, 2 and 3 years post‐CXL treatment using the Oculus Pentacam.Results: Results showed a significant improvement in CDVA on logMAR chart (0.19 ± 0.41, p = 0.04) at 3 years follow‐up. Kmax reduced significantly by 1.61 ± 3.02D, p = 0.02 (from 64.35 ± 6.85D to 63.19 ± 6.99D) at 3 years after CXL. Pachymetry measurements showed a significant reduction at 1 year (p = 0.01), 2 years (p = 0.00005) and 3 years (p = 0.000002) following CXL. CXL induced a significant reduction in Kmax measurements in Group A at 3 years follow‐up (1.50 ± 2.17D, p = 0.02); however, there was no significant change observed at 3 years following CXL in Group B (p = 0.19). Kmax reduced or at least stabilised in all patients in Group A at 3 years follow‐up; however, 25% of eyes in Group B showed a Kmax worsening of ≥1D.Conclusions: The findings of the current study show the effectiveness of CXL to stabilise the progression of keratoconus and significantly improve corneal curvature measurements. The progression of keratoconus is more likely to stabilise after CXL in eyes with lower Kmax measurements.

12 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NCNaveen Challa
Naveen Challa
NANawaf M Almutairi
Nawaf M Almutairi
Bandar M. AleneziBandar M. Alenezi
Bandar M. Alenezi
AEAbd Elaziz Mohamed Elmadina
Abd Elaziz Mohamed Elmadina
Purpose: To report baseline anterior scleral thickness (AST) values and evaluate regional and sex-related variation in healthy young Saudi adults using swept-source optical coherence tomography (SS-OCT). Methods: A prospective, cross-sectional study included 55 healthy Saudi adults aged 18–40 years. Participants underwent comprehensive ocular examinations to exclude pathology or significant refractive errors. AST was measured using IMAGEnet 6 software in superior, inferior, nasal, and temporal quadrants at 0 mm, 1 mm, and 2 mm from the scleral spur using the anterior segment module of swept-source OCT. Regional and sex-related differences were evaluated using a linear mixed-effects model adjusted for age and spherical equivalent. Short-term within-session intra-observer test–retest repeatability across repeated B-scan acquisitions was assessed using intraclass correlation coefficients, within-subject coefficients of variation, and Bland–Altman analysis. Results: The mean age of participants was 23.56 ± 4.61 years (34 males, 21 females). AST varied significantly according to distance and anatomical quadrant (both p < 0.001), with significant distance-by-quadrant (p < 0.001) and sex-by-distance-by-quadrant interactions (p = 0.010). The inferior quadrant generally showed greater thickness, while the superior quadrant showed lower values. Bonferroni-adjusted location-specific comparisons showed greater AST in males in the superior and temporal quadrants at both 1 mm and 2 mm from the scleral spur, whereas the remaining sex comparisons were not statistically significant. Neither age nor spherical equivalent showed a significant independent association with AST. Intra-observer ICC values ranged from 0.872 to 0.939. Conclusions: AST in young Saudi adults varies according to anatomical quadrant and distance from the scleral spur, with sex-related differences showing location-dependent patterns. These findings provide descriptive baseline data for anterior scleral morphology in this population.

2 March 2026 in Translational Vision Science & Technology
Verified
Journal Article
Open access
Bandar M. AleneziBandar M. Alenezi
Bandar M. Alenezi
FKFadil Khoyratty
Fadil Khoyratty
SBSusmito Biswas
Susmito Biswas
YAYousef S. Alshammari
Yousef S. Alshammari
SASulaiman Aldakhil
Sulaiman Aldakhil
HRHema Radhakrishnan
Hema Radhakrishnan
To investigate the effect of corneal cross-linking (CXL) on corneal curvature and thickness in two different keratoconic populations, one based in the Middle East (Saudi Arabia) and one in Europe (UK), and to explore whether age and ethnicity play a role in CXL outcomes. This study included 208 eyes of 197 keratoconic patients (130 males and 67 females; ages 13-52 years) for the UK cohort and 362 eyes of 329 keratoconic patients (226 males and 136 females; ages 12-51 years) were included for the Saudi cohort. All patients underwent epithelium-off accelerated CXL (ultraviolet-A irradiation of 10 mW/cm2 for 9 minutes) and riboflavin 0.1% solution in both locations. Patients were divided into three age groups: ≤18 years, 19 to 27 years, and ≥28 years. CXL outcomes were assessed using Scheimpflug imaging during 3-year follow-ups and compared across cohorts from both countries. Baseline maximum keratometry (Kmax) and pachymetry were 64.32 ± 8.07 D and 441 ± 33.52 µm for the UK cohort and 54.60 ± 7.59 D and 462 ± 36.38 µm for the Saudi cohort, respectively. At 3 years post-CXL, Kmax improved or stabilized (change in Kmax > -1 D) in 47 eyes (82.45%) in the UK cohort and in 188 eyes (84.30%) in the Saudi cohort, with significant improvements of 1.30 ± 3.00 D (P = 0.003) and 1.2 ± 2.91 D (P < 0.001), respectively. Pachymetry was significantly reduced for both cohorts (P = 0.001 and P < 0.001, respectively). Kmax did not show significant changes in any age group post-CXL in the UK cohort, whereas Kmax significantly improved in all age groups in the Saudi cohort. Keratoconus presented at a more severe stage in the UK cohort compared to the Saudi cohort. Despite this difference in baseline severity, CXL contributed to stabilize keratoconus progression in most patients in both populations. When each cohort was considered independently, the effect of CXL was comparable across all age groups, with no age group demonstrating greater benefit. This work identified the effectiveness of CXL for keratoconus at different severities and for different age groups and ethnicities, suggesting the significance of facilitating access to CXL to maximize treatment outcomes.